Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report

Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report

Abstract Background The advent of immune checkpoint inhibitors (ICIs) has significantly improved the prognosis of patients with advanced malignancies. On the other hand, these drugs might cause immune-related adverse events (irAEs) including endocrinopathies and nephropathies. Thyroid dysfunction is...

Full description

Bibliographic Details
Main Authors: Natsumi Matsuoka, Kenji Tsuji, Eiki Ichihara, Takayuki Hara, Kazuhiko Fukushima, Kishio Toma, Shinji Kitamura, Kenichi Inagaki, Hitoshi Sugiyama, Jun Wada
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Nephrology
Subjects:
Pembrolizumab
Hypothyroidism
Creatinine
Cystatin C
Online Access:http://link.springer.com/article/10.1186/s12882-020-01775-z

Internet

http://link.springer.com/article/10.1186/s12882-020-01775-z

Similar Items